Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrante

Showing results (1-10 of 350) with videos related to

Pageof 35
Sort By:
Gastroenterology & Hepatology|May 26, 2021
Current Use of Fecal Calprotectin in the Management of Patients With Inflammatory Bowel DiseaseMarc Ferrante
Alimentary Pharmacology & Therapeutics|March 23, 2023
Editorial: risankizumab - ready to break ceilings?Marc Ferrante
Clinical and Experimental Gastroenterology|June 24, 2021
Chronic Antibiotic-Refractory Pouchitis: Management ChallengesAn Outtier, Marc Ferrante
Alimentary Pharmacology & Therapeutics|March 13, 2020
Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era-getting nearer?Bram Verstockt, Marc Ferrante
Digestive Diseases and Sciences|December 5, 2024
Needle or Drip?-Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel DiseasesAn Outtier, Marc Ferrante
Journal of Crohn'S & Colitis|December 28, 2019
Efficacy of JAK inhibitors in Ulcerative ColitisMarc Ferrante, João Sabino
Journal of Crohn'S & Colitis|September 30, 2017
Management of Postoperative Crohn's Disease: Missing Pieces of the PuzzlePauline Rivière, Marc Ferrante
Journal of Crohn'S & Colitis|July 17, 2018
Failure of MMP-9 Antagonists in IBD: Demonstrating the Importance of Molecular Biology and Well-Controlled Early Phase StudiesMagali de Bruyn, Marc Ferrante
Current Drug Targets|June 6, 2012
Medical therapy and mucosal healingMarc Ferrante, Gert Van Assche
Gastroenterology|February 12, 2022
Severe Necrotizing Colitis in a 45-Year-Old Woman Without a Cardiovascular HistoryFrancesca Decraene, Daniel Blockmans, Marc Ferrante
Pageof 35

Showing results (1-10 of 350) with videos related to

Sort By:
Pageof 35
Gastroenterology & Hepatology|May 26, 2021
Current Use of Fecal Calprotectin in the Management of Patients With Inflammatory Bowel DiseaseMarc Ferrante
Alimentary Pharmacology & Therapeutics|March 23, 2023
Editorial: risankizumab - ready to break ceilings?Marc Ferrante
Clinical and Experimental Gastroenterology|June 24, 2021
Chronic Antibiotic-Refractory Pouchitis: Management ChallengesAn Outtier, Marc Ferrante
Alimentary Pharmacology & Therapeutics|March 13, 2020
Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era-getting nearer?Bram Verstockt, Marc Ferrante
Digestive Diseases and Sciences|December 5, 2024
Needle or Drip?-Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel DiseasesAn Outtier, Marc Ferrante
Journal of Crohn'S & Colitis|December 28, 2019
Efficacy of JAK inhibitors in Ulcerative ColitisMarc Ferrante, João Sabino
Journal of Crohn'S & Colitis|September 30, 2017
Management of Postoperative Crohn's Disease: Missing Pieces of the PuzzlePauline Rivière, Marc Ferrante
Journal of Crohn'S & Colitis|July 17, 2018
Failure of MMP-9 Antagonists in IBD: Demonstrating the Importance of Molecular Biology and Well-Controlled Early Phase StudiesMagali de Bruyn, Marc Ferrante
Current Drug Targets|June 6, 2012
Medical therapy and mucosal healingMarc Ferrante, Gert Van Assche
Gastroenterology|February 12, 2022
Severe Necrotizing Colitis in a 45-Year-Old Woman Without a Cardiovascular HistoryFrancesca Decraene, Daniel Blockmans, Marc Ferrante
Pageof 35